| Melissa P Taylor, MD | |
|
271 Medical Park Blvd, Bristol, TN 37620-7455 | |
| (423) 274-8600 | |
| (423) 390-6845 |
| Full Name | Melissa P Taylor |
|---|---|
| Gender | Female |
| Speciality | Cardiac Surgery |
| Experience | 11 Years |
| Location | 271 Medical Park Blvd, Bristol, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801235742 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 63271 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wellmont Bristol Regional Medical Center | Bristol, TN | Hospital |
| Johnson City Medical Center | Johnson city, TN | Hospital |
| Wellmont Holston Valley Medical Center | Kingsport, TN | Hospital |
| Johnston Memorial Hospital | Abingdon, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellmont Cardiology Services | 5799970281 | 130 |
News Archive
The WHO's recent prequalification approval of a low-cost meningitis vaccine could "help prevent epidemics in Africa for the first time, revolutionizing how doctors fight outbreaks of the deadly disease," the Associated Press reports.
An experimental vaccine based on a virus that causes encephalitis in the wild appears to block tumor growth in some cases of advanced cancer, according to researchers at Duke University Medical Center. Scientists say the vaccine is able to stimulate an immune response, even in the face of profound immune system suppression, a condition most patients with advanced cancer experience.
An international study published in the Journal of the National Cancer Institute has identified a genetic connection to the aggressive form of prostate cancer.
Researchers from Harvard Medical School and MIT have developed a new approach for identifying the "self" proteins targeted in autoimmune diseases such as multiple sclerosis, diabetes and rheumatoid arthritis.
Cardiologists are quick to point to statistics showing that the "door-to-balloon" treatment time for heart attack patients has dropped significantly in the past few years. But a retrospective study reveals that those who call 911 are most likely to have suffered a severe heart attack and despite receiving treatment quickly, they are still dying at unacceptable rates, say researchers at The University of Texas Health Science Center at Houston.
› Verified 4 days ago
| Entity Name | Wellmont Cardiology Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376575035 PECOS PAC ID: 5799970281 Enrollment ID: O20101215000083 |
News Archive
The WHO's recent prequalification approval of a low-cost meningitis vaccine could "help prevent epidemics in Africa for the first time, revolutionizing how doctors fight outbreaks of the deadly disease," the Associated Press reports.
An experimental vaccine based on a virus that causes encephalitis in the wild appears to block tumor growth in some cases of advanced cancer, according to researchers at Duke University Medical Center. Scientists say the vaccine is able to stimulate an immune response, even in the face of profound immune system suppression, a condition most patients with advanced cancer experience.
An international study published in the Journal of the National Cancer Institute has identified a genetic connection to the aggressive form of prostate cancer.
Researchers from Harvard Medical School and MIT have developed a new approach for identifying the "self" proteins targeted in autoimmune diseases such as multiple sclerosis, diabetes and rheumatoid arthritis.
Cardiologists are quick to point to statistics showing that the "door-to-balloon" treatment time for heart attack patients has dropped significantly in the past few years. But a retrospective study reveals that those who call 911 are most likely to have suffered a severe heart attack and despite receiving treatment quickly, they are still dying at unacceptable rates, say researchers at The University of Texas Health Science Center at Houston.
› Verified 4 days ago
| Entity Name | Wellmont Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780986257 PECOS PAC ID: 8123291739 Enrollment ID: O20111026000909 |
News Archive
The WHO's recent prequalification approval of a low-cost meningitis vaccine could "help prevent epidemics in Africa for the first time, revolutionizing how doctors fight outbreaks of the deadly disease," the Associated Press reports.
An experimental vaccine based on a virus that causes encephalitis in the wild appears to block tumor growth in some cases of advanced cancer, according to researchers at Duke University Medical Center. Scientists say the vaccine is able to stimulate an immune response, even in the face of profound immune system suppression, a condition most patients with advanced cancer experience.
An international study published in the Journal of the National Cancer Institute has identified a genetic connection to the aggressive form of prostate cancer.
Researchers from Harvard Medical School and MIT have developed a new approach for identifying the "self" proteins targeted in autoimmune diseases such as multiple sclerosis, diabetes and rheumatoid arthritis.
Cardiologists are quick to point to statistics showing that the "door-to-balloon" treatment time for heart attack patients has dropped significantly in the past few years. But a retrospective study reveals that those who call 911 are most likely to have suffered a severe heart attack and despite receiving treatment quickly, they are still dying at unacceptable rates, say researchers at The University of Texas Health Science Center at Houston.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melissa P Taylor, MD 509 Med Tech Pkwy Ste 100, Johnson City, TN 37604-2579 Ph: (423) 302-6565 | Melissa P Taylor, MD 271 Medical Park Blvd, Bristol, TN 37620-7455 Ph: (423) 274-8600 |
News Archive
The WHO's recent prequalification approval of a low-cost meningitis vaccine could "help prevent epidemics in Africa for the first time, revolutionizing how doctors fight outbreaks of the deadly disease," the Associated Press reports.
An experimental vaccine based on a virus that causes encephalitis in the wild appears to block tumor growth in some cases of advanced cancer, according to researchers at Duke University Medical Center. Scientists say the vaccine is able to stimulate an immune response, even in the face of profound immune system suppression, a condition most patients with advanced cancer experience.
An international study published in the Journal of the National Cancer Institute has identified a genetic connection to the aggressive form of prostate cancer.
Researchers from Harvard Medical School and MIT have developed a new approach for identifying the "self" proteins targeted in autoimmune diseases such as multiple sclerosis, diabetes and rheumatoid arthritis.
Cardiologists are quick to point to statistics showing that the "door-to-balloon" treatment time for heart attack patients has dropped significantly in the past few years. But a retrospective study reveals that those who call 911 are most likely to have suffered a severe heart attack and despite receiving treatment quickly, they are still dying at unacceptable rates, say researchers at The University of Texas Health Science Center at Houston.
› Verified 4 days ago
William H Messerschmidt, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Park Blvd, Suite 458w, Bristol, TN 37620 Phone: 423-439-7201 Fax: 423-439-7219 | |
Marcus G Williams, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Park Blvd, Suite 458w, Bristol, TN 37620 Phone: 423-230-6900 Fax: 423-844-4987 |